Leslie Arceneaux is an Associate Professor and Director for Continuing Education & Development at Georgetown University School of Nursing. She joined Georgetown University School of Nursing and Health Studies in 2011 as an Assistant Professor and teaches in the Core and FNP program. Dr. Arceneaux served as a clinical faculty advisor in the FNP program, Advanced Health Assessment course coordinator (2015) and the on campus intensive assessment coordinator (2015). In 2017 to 2019, she became the Assistant Core program director. In 2019 to 2023, Dr. Arceneaux was promoted as the Core Program Director. Since July of 2023, Dr. Arceneaux has served as the Director for Continuing Education & Development in addition to teaching, coordinating Advanced Health Assessment, and mentoring DNP students.
Dr. Arceneaux has 40 years of experience as an RN, and 20 years as a family nurse practitioner. She is also certified as a diabetic educator and serves as a diabetes consultant. In 2005 she received her Doctorate of Nursing Practice from the University of South Alabama, where she received the award for clinical excellence. Dr. Arceneaux has many years of service in various areas of clinical practice including primary care, women’s health, pediatrics, diabetes, and gastroenterology focusing much of her career on chronic disease prevention. She has participated in numerous diabetes research studies including the effects of diabetes education on chronic disease prevention and on new pharmacological treatment therapies.
Dr. Arceneaux is an associate member of the Centile Teaching Academy at Georgetown and has been an invited speaker for national and local conferences. She has served as a reviewer for the Journal of the Association of Nurse Practitioners and the Journal of Doctoral Nursing Practice. Dr. Arceneaux’s clinical scholarship includes prevention of colorectal cancer and on evaluation and treatment of gastrointestinal bleeding. Her scholarship in patient education includes research in controlling and preventing the complications of type 2 diabetes and developing an open access colonoscopy system to increase screenings to prevent colorectal cancer. Dr. Arceneaux presently continues her clinical practice with an underserved diabetes population.